Krupp Nadia L, Fiscus Cindy, Webb Russell, Webber Emily C, Stanley Teresa, Pettit Rebecca, Davis Ashley, Hollingsworth Judy, Bagley Deborah, McCaskey Marjorie, Stevens John C, Weist Andrea, Cristea A Ioana, Warhurst Heather, Bauer Benjamin, Saysana Michele, Montgomery Gregory S, Howenstine Michelle S, Davis Stephanie D
a Department of Pediatrics , Indiana University School of Medicine , Indianapolis , IN , USA.
b Riley Hospital for Children at Indiana University Health , Indianapolis , IN , USA.
J Asthma. 2017 Nov;54(9):911-918. doi: 10.1080/02770903.2017.1281294. Epub 2017 Jan 24.
Asthma is the most common chronic disease of childhood and a leading cause of hospitalization in children. A primary goal of asthma control is prevention of hospitalizations. A hospital admission is the single strongest predictor of future hospital admissions for asthma. The 30-day asthma readmission rate at our institution was significantly higher than that of other hospitals in the Children's Hospital Association. As a result, a multifaceted quality improvement project was undertaken with the goal of reducing the 30-day inpatient asthma readmission rate by 50% within two years.
Analysis of our institution's readmission patterns, value stream mapping of asthma admission, discharge, and follow-up processes, literature review, and examination of comparable successful programs around the United States were all utilized to identify potential targets for intervention. Interventions were implemented in a stepwise manner, and included increasing inhaler availability after discharge, modifying asthma education strategies, and providing in-home post-discharge follow-up. The primary outcome was a running 12-month average 30-day inpatient readmission rate. Secondary outcomes included process measures for individual interventions.
From a peak of 7.98% in January 2013, a steady decline to 1.65% was observed by July 2014, which represented a 79.3% reduction in 30-day readmissions.
A significant decrease in hospital readmissions for pediatric asthma is possible, through comprehensive, multidisciplinary quality improvement that spans the continuum of care.
哮喘是儿童最常见的慢性疾病,也是儿童住院治疗的主要原因之一。哮喘控制的首要目标是预防住院。哮喘患者再次入院是未来哮喘再次入院的最强单一预测因素。我院30天哮喘再入院率显著高于儿童医院协会的其他医院。因此,我们开展了一个多方面的质量改进项目,目标是在两年内将30天住院哮喘再入院率降低50%。
分析我院的再入院模式、哮喘入院、出院及随访流程的价值流图、文献综述以及研究美国各地类似的成功项目,以确定潜在的干预目标。干预措施逐步实施,包括出院后增加吸入器的可及性、修改哮喘教育策略以及提供出院后家庭随访。主要结局是连续12个月的30天住院再入院率平均值。次要结局包括各项干预措施的过程指标。
从2013年1月的峰值7.98%开始,到2014年7月观察到稳步下降至1.65%,这代表30天再入院率降低了79.3%。
通过全面、多学科的质量改进,涵盖连续的医疗护理过程,小儿哮喘的医院再入院率有可能显著降低。